Legal Affairs

BLAZE Launches Herbie AI Budtender for Cannabis E-Commerce

ANAHEIM – BLAZE, an AI-powered retail technology suite specifically designed for Cannabis dispensaries, delivery services, payments, and e-commerce has introduced Herbie AI Budtender – the virtual assistant providing personalized product guidance to customers shopping online. ...

SNDL Reports Q4 and FY 2025 Financial Results

EDMONTON – SNDL Inc. disclosed its fourth-quarter and full-year 2025 earnings for the period ended December 31, 2025, illustrating a clear divergence in performance across its two main retail pillars: sustained progress and margin expansion ...

Ascend Wellness Reports Q4 and FY 2025 Financial Results

NEW YORK – Ascend Wellness Holdings Inc. released its fourth-quarter and full-year 2025 earnings, underscoring a calculated shift among MSOs toward operational and margin discipline in response to persistent industry challenges. The disclosure illustrates how ...

BLAZE Launches Herbie AI Budtender for Cannabis E-Commerce

ANAHEIM – BLAZE, an AI-powered retail technology suite specifically designed for Cannabis dispensaries, delivery services, payments, and e-commerce has introduced Herbie AI Budtender – the virtual assistant providing personalized product guidance to customers shopping online. ...

COMPASS Pathways Receives Analyst Ratings

LOS ANGELES- COMPASS Pathways, a company specializing in mental health treatments, has garnered significant attention in recent market reports due to favorable analyst ratings and its stock performance. Several brokerages have maintained a consensus "Buy" ...

Verano Holdings to Participate in Key Investor Conferences

LOS ANGELES- Verano Holdings Corp. U.S. multi-state cannabis company, has announced its participation in two significant industry conferences. The company’s executives will engage with investors and industry leaders to discuss important market developments and future ...

MindMed to Present at Key September Investor Conferences

LOS ANGELES- Mind Medicine (MindMed) Inc., a clinical-stage biopharmaceutical company focused on developing novel treatments for brain health disorders, announced its participation in three significant investor conferences in September 2024. MindMed’s management team will engage ...

Subscribe To Our Newsletter